Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
159.03B | 158.25B | 140.94B | 116.31B | 92.97B | 120.58B | Gross Profit |
13.45B | 13.90B | 10.48B | 7.62B | 6.57B | 12.04B | EBIT |
1.57B | 2.29B | 23.00M | -2.42B | -2.55B | 764.00M | EBITDA |
528.50M | 5.10B | 12.93B | 8.45B | 10.54B | 15.09B | Net Income Common Stockholders |
-10.64B | -7.70B | -84.00M | -5.19B | -2.84B | -685.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
12.32B | 12.32B | 12.99B | 9.36B | 12.25B | 4.17B | Total Assets |
131.76B | 131.76B | 137.07B | 131.30B | 132.22B | 123.05B | Total Debt |
41.27B | 40.52B | 43.52B | 42.92B | 45.92B | 33.70B | Net Debt |
29.67B | 28.20B | 30.53B | 33.56B | 33.67B | 29.53B | Total Liabilities |
80.04B | 80.15B | 80.42B | 77.74B | 76.59B | 65.69B | Stockholders Equity |
51.62B | 51.62B | 56.65B | 53.57B | 55.63B | 57.36B |
Cash Flow | Free Cash Flow | ||||
0.00 | 5.20B | 839.00M | -989.00M | -3.89B | -1.90B | Operating Cash Flow |
0.00 | 18.32B | 10.73B | 8.26B | 7.94B | 16.47B | Investing Cash Flow |
0.00 | -13.94B | -6.33B | -6.08B | -11.57B | -17.69B | Financing Cash Flow |
0.00 | -5.95B | -1.53B | -5.10B | 11.94B | 2.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | €26.49B | 9.95 | 3.84% | 3.39% | 5.05% | 183.01% | |
71 Outperform | $1.03T | 12.68 | 7.19% | 4.38% | 4.48% | -51.81% | |
67 Neutral | ¥186.44B | 24.84 | 1.76% | 2.31% | -23.23% | ||
67 Neutral | ¥195.52B | 23.20 | 5.06% | 3.58% | -17.59% | ||
64 Neutral | $4.42B | 11.99 | 5.16% | 249.23% | 4.02% | -11.68% | |
57 Neutral | ¥50.94B | 7.80 | 4.70% | -12.06% | -30.83% | ||
52 Neutral | ¥15.61B | ― | 4.54% | 2.35% | -763.33% |
Ahresty Corporation announced an expected recording of extraordinary losses due to impairment losses at its U.S. subsidiary, Ahresty Wilmington Corporation, driven by high personnel turnover and rising costs. Despite these challenges, the company aims to improve profitability at its U.S. plant through enhanced support from Japan and optimization of its product portfolio. The company has revised its consolidated full-year results forecast, with net sales and operating profit slightly increasing, but profit attributable to owners of the parent expected to fall due to the impairment loss. The year-end dividend projection remains unchanged.
Ahresty Corporation announced the transfer of all equity interests in its sub-subsidiary, Ahresty Precision Die Mold (Guangzhou) Co., Ltd., to Guangzhou Jinzhang Plastic Products Co., Ltd. This strategic move is a response to declining orders from its major customers due to increased competition in the automotive sector. The transfer is part of Ahresty’s effort to restructure its business portfolio and reallocate resources to more promising global growth markets, reflecting a significant shift in its operational strategy.